(Q45271743)
Statements
1 reference
Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications (English)
1 reference
Olga Geling
1 reference
Hans-Georg Eichler
1 reference
1 February 2005
1 reference
1 reference
Identifiers
1 reference